RIGS guided adoptive cellular therapy data

NEOP announced that three of nine patients in an investigator-initiated pilot study showed regression of tumor, with one patient having complete remission and four others having stable disease for six months. Tumor size was measured by CT scan. Two patients' disease progressed. Most had undergone chemotherapy with no benefit. ...